Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

81. Effect of a Mammography Screening Decision Aid for Women 75 Years and Older: A Cluster Randomized Clinical Trial

Effect of a Mammography Screening Decision Aid for Women 75 Years and Older: A Cluster Randomized Clinical Trial Effect of a Mammography Screening Decision Aid for Women 75 Years and Older: A Cluster Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine (...) JAMA Intern Med Actions . 2020 Apr 20;e200440. doi: 10.1001/jamainternmed.2020.0440. Online ahead of print. Effect of a Mammography Screening Decision Aid for Women 75 Years and Older: A Cluster Randomized Clinical Trial , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Division of General Medicine, Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts. 2 Division of Geriatric Medicine, Department of Medicine, The University

2020 EvidenceUpdates

82. Position Statement on COVID-19 and Acute Heart Failure: screening the critically ill

Position Statement on COVID-19 and Acute Heart Failure: screening the critically ill 1 COVID-19 and acute heart failure: screening the critically ill Sean Lal 1* , Christopher Hayward 2* , Carmine De Pasquale 3 , David Kaye 4 , George Javorsky 5 , Peter Bergin 4 , John Atherton 12 , Marcus Ilton 6 , Robert Weintraub 7 , Priya Nair 2 , Mate Rudas 1 , Lawrence Dembo 10 , Robert Doughty 11 , Gayathri Kumarasinghe 13 , Craig Juergens 13 , Paul Bannon 1 , Nicole Bart 2 , Clara Chow 8 , Jo-Dee (...) /4/20 2 There is a need to screen for acute heart failure in critically ill COVID-19 patients. Up to one- third of COVID-19 patients who are admitted to the ICU, albeit a select population, develop an acute cardiomyopathy [1], which could represent myocarditis or stress cardiomyopathy. Fulminant myocarditis has been identified as a cause of death in younger patients with Middle East Respiratory Syndrome [2], and a similar trend may follow with COVID-19, even though younger age groups comprise

2020 Cardiac Society of Australia and New Zealand

83. Screening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US Preventive Services Task Force Recommendation Statement. Full Text available with Trip Pro

Screening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US Preventive Services Task Force Recommendation Statement. Bacterial vaginosis is common and is caused by a disruption of the microbiological environment in the lower genital tract. In the US, reported prevalence of bacterial vaginosis among pregnant women ranges from 5.8% to 19.3% and is higher in some races/ethnicities. Bacterial vaginosis during pregnancy has been associated with adverse obstetrical outcomes (...) including preterm delivery, early miscarriage, postpartum endometritis, and low birth weight.To update its 2008 recommendation, the USPSTF commissioned a review of the evidence on the accuracy of screening and the benefits and harms of screening for and treatment of bacterial vaginosis in asymptomatic pregnant persons to prevent preterm delivery.This recommendation applies to pregnant persons without symptoms of bacterial vaginosis.The USPSTF concludes with moderate certainty that screening

2020 JAMA

84. Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening

Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening Recommendation | United States Preventive Services Taskforce Toggle navigation Main navigation Main navigation Recommendation Pregnant persons not at increased risk for preterm delivery The USPSTF recommends against screening for bacterial vaginosis (BV) in pregnant persons who are not at increased risk for preterm delivery. D Pregnant persons at increased risk for preterm delivery The USPSTF concludes (...) that the current evidence is insufficient to assess the balance of benefits and harms of screening for BV in pregnant persons who are at increased risk for preterm delivery. I View the Clinical Summary in What does the USPSTF recommend? For pregnant persons not at increased risk for preterm delivery: Grade D Do not screen for bacterial vaginosis in pregnant persons who have no signs or symptoms of bacterial vaginosis. For pregnant persons at increased risk for preterm delivery: I statement The evidence

2020 U.S. Preventive Services Task Force

85. COVID-19 Clinical Screening Assessment Tool

COVID-19 Clinical Screening Assessment Tool COVID-19 CLINICAL SCREENING ASSESSMENT DO NOT WRITE IN THIS BINDING MARGIN Page 1 of 1 label here) URN: Family name: Given name(s): Address: Date of birth: Sex: M F I COVID-19 Clinical Screening Assessment Facility: v3.00 - 04/2020 Do not reproduce by photocopying SW998 2020 Name: Designation: Signature: Date: 1. Reason for Presentation: 2. Recent international travel history No Yes (in the 14 days prior to illness onset) 3. Location of recent travel (...) : Temperature: 11. Additional Information: 12. Outcome Advice only - no testing required based on guidelines at time of screening assessment Instructed to self-quarantine and present for testing if becomes symptomatic Tested - follow up required (patient instructed to self-isolate) Refer for Direct Admission Refer to Emergency Department Refer to GP Refer to QH Clinic Other: For further information on current guidelines visit Australian Government: The Department of Health website: https://www1

2020 Queensland Health

86. ASCCP Interim Guidance for Timing of Diagnostic and Treatment Procedures for Patients with Abnormal Cervical Screening Tests

ASCCP Interim Guidance for Timing of Diagnostic and Treatment Procedures for Patients with Abnormal Cervical Screening Tests COVID-19 - ASCCP ');//]]> Register Today! Virtual Conference Starting Soon. Colposcopy Standards Recommendations Recommendations on New Standards of Colposcopy Practice Webinars Live and On-Demand Member Resources ASCCP Interim Guidance for Timing of Diagnostic and Treatment Procedures for Patients with Abnormal Cervical Screening Tests March 19, 2020 - In light (...) of the current unprecedented COVID-19 pandemic, and in settings where all non-essential medical office visits and elective procedures have been suspended, ASCCP recommends the following: Individuals with low-grade cervical cancer screening tests may have postponement of diagnostic evaluations up to 6-12 months. Individuals with high-grade cervical cancer screening tests should have documented attempts to contact and diagnostic evaluation scheduled within 3 months. Individuals with high-grade cervical disease

2020 American Society for Clinical Pathology

87. Screening for Hepatitis C Virus Infection

Screening for Hepatitis C Virus Infection Screening for Hepatitis C Virus Infection | ACOG Clinical Guidance Journals & Publications Patient Education Topics Featured Clinical Topics Hi, Featured Clinical Topics Clinical Guidance Screening for Hepatitis C Virus Infection Practice Advisory April 2020 Jump to Resources Share By reading this page you agree to ACOG's Terms and Conditions. . The on March 2, 2020. New guidance from both the CDC and the USPSTF represent a change in routine screening (...) for HCV; both organizations now recommend HCV screening for all adults, including pregnant and nonpregnant individuals. The American College of Obstetricians and Gynecologists (ACOG) is actively reviewing the new guidance from the CDC and USPSTF. Updated guidance from ACOG will be posted on ACOG’s website and published in Obstetrics & Gynecology when available. ACOG is also reviewing its current guidance on the screening and management of hepatitis for pregnant individuals in ACOG Practice Bulletin

2020 American College of Obstetricians and Gynecologists

88. Legal Considerations in Genetic Screening and Testing: Three Case Studies

Legal Considerations in Genetic Screening and Testing: Three Case Studies Legal Considerations in Genetic Screening and Testing: Three Case Studies | ACOG Clinical Guidance Journals & Publications Patient Education Topics Featured Clinical Topics Hi, Featured Clinical Topics Clinical Guidance Legal Considerations in Genetic Screening and Testing: Three Case Studies Committee Opinion Number 805 April 2020 Jump to Resources Share By reading this page you agree to ACOG's Terms and Conditions (...) and Gynecologists’ documents, including Committee Opinion No. 777 Sexual Assault and Committee Opinion No. 518 Intimate Partner Violence for further resources. Adequate pretest counseling and screening, including an extensive family history, may help to avoid discovering information unexpectedly. Patients should be made aware that information about blood relatedness may be revealed by some prenatal genetic tests. Because of the complex genetic, ethical, and legal implications of discovering such information

2020 American College of Obstetricians and Gynecologists

89. Utility of MyHEARTSMAP for Universal Psychosocial Screening in the Emergency Department

Utility of MyHEARTSMAP for Universal Psychosocial Screening in the Emergency Department Utility of MyHEARTSMAP for Universal Psychosocial Screening in the Emergency Department - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health U.S. National Library (...) navigation J Pediatr Actions . 2020 Apr;219:54-61.e1. doi: 10.1016/j.jpeds.2019.12.046. Epub 2020 Feb 24. Utility of MyHEARTSMAP for Universal Psychosocial Screening in the Emergency Department , , , , , , , , , Affiliations Expand Affiliations 1 Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: qdoan@bcchr.ca. 2 Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. 3 Faculty of Medicine, University of British Columbia

2020 EvidenceUpdates

90. Screening strategies to identify sepsis in the prehospital setting: a validation study Full Text available with Trip Pro

Screening strategies to identify sepsis in the prehospital setting: a validation study Screening Strategies to Identify Sepsis in the Prehospital Setting: A Validation Study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health U.S. National Library (...) navigation CMAJ Actions . 2020 Mar 9;192(10):E230-E239. doi: 10.1503/cmaj.190966. Screening Strategies to Identify Sepsis in the Prehospital Setting: A Validation Study , , , , , , Affiliations Expand Affiliations 1 Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health (Lane, Wunsch, Saskin, Lin, Scales), Interdepartmental Division of Critical Care (Wunsch, Scales), Division of Emergency Medicine, Department of Family and Community Medicine (Cheskes), and Division

2020 EvidenceUpdates

91. Diagnostic Yield of Newborn Screening for Biliary Atresia Using Direct or Conjugated Bilirubin Measurements. Full Text available with Trip Pro

Diagnostic Yield of Newborn Screening for Biliary Atresia Using Direct or Conjugated Bilirubin Measurements. Treating biliary atresia in newborns earlier can delay or prevent the need for liver transplant; however, treatment typically occurs later because biliary atresia is difficult to detect during its early stages.To determine the diagnostic yield of newborn screening for biliary atresia with direct or conjugated bilirubin measurements and to evaluate the association of screening (...) implementation with clinical outcomes.A cross-sectional screening study of 124 385 infants born at 14 Texas hospitals between January 2015 and June 2018; and a pre-post study of 43 infants who underwent the Kasai portoenterostomy as treatment for biliary atresia at the region's largest pediatric hepatology center before (January 2008-June 2011) or after (January 2015-June 2018) screening implementation. Final follow-up occurred on July 15, 2019.Two-stage screening with direct or conjugated bilirubin

2020 JAMA

92. Continuation of Annual Screening Mammography and Breast Cancer Mortality in Women Older Than 70 Years. (Abstract)

Continuation of Annual Screening Mammography and Breast Cancer Mortality in Women Older Than 70 Years. Randomized trials have shown that initiating breast cancer screening between ages 50 and 69 years and continuing it for 10 years decreases breast cancer mortality. However, no trials have studied whether or when women can safely stop screening mammography. An estimated 52% of women aged 75 years or older undergo screening mammography in the United States.To estimate the effect of breast cancer (...) screening on breast cancer mortality in Medicare beneficiaries aged 70 to 84 years.Large-scale, population-based, observational study of 2 screening strategies: continuing annual mammography, and stopping screening.U.S. Medicare program, 2000 to 2008.1 058 013 beneficiaries aged 70 to 84 years who had a life expectancy of at least 10 years, had no previous breast cancer diagnosis, and underwent screening mammography.Eight-year breast cancer mortality, incidence, and treatments, plus the positive

2020 Annals of Internal Medicine

93. Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. Full Text available with Trip Pro

Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. HCV is associated with more deaths than the top 60 other reportable infectious diseases combined, including HIV. Cases of acute HCV infection have increased approximately 3.8-fold over the last decade because of increasing (...) injection drug use and improved surveillance.To update its 2013 recommendation, the USPSTF commissioned a review of the evidence on screening for HCV infection in adolescents and adults.This recommendation applies to all asymptomatic adults aged 18 to 79 years without known liver disease.The USPSTF concludes with moderate certainty that screening for HCV infection in adults aged 18 to 79 years has substantial net benefit.The USPSTF recommends screening for HCV infection in adults aged 18 to 79 years. (B

2020 JAMA

94. Shared follow-up and survivorship care for low-risk endometrial cancer: Screening, assessment and management of supportive care needs of women with low-risk endometrial cancer

Shared follow-up and survivorship care for low-risk endometrial cancer: Screening, assessment and management of supportive care needs of women with low-risk endometrial cancer canceraustralia.gov.au Screening, assessment and management of supportive care needs of women with low-risk endometrial cancer This resource is for all members of the multidisciplinary shared care team. It provides guidance on the screening, assessment and management of supportive care needs of women affected by low-risk (...) . Screening, assessing and managing the effects of treatment, co-morbidities and secondary prevention are important aspects of a holistic and multidisciplinary approach to managing follow-up care for women with low-risk endometrial cancer. Referral to appropriate health providers is required to meet the identified needs of the woman, her carer and family. SHARED FOLLOW-UP AND SURVIVORSHIP CARE FOR LOW-RISK ENDOMETRIAL CANCER * Evidence suggests that cardiovascular disease is the leading cause of death

2020 Cancer Australia

95. Cervical screening: ideas for improving access and uptake

Cervical screening: ideas for improving access and uptake Cervical screening: ideas for improving access and uptake - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Cervical screening: ideas for improving access and uptake Guidance to help primary care, commissioners and local (...) authorities plan and evaluate initiatives around cervical screening coverage in their area. Published 3 March 2020 From: Contents The following initiatives can be used to address areas of low coverage identified in the cervical screening quarterly coverage data reports. Invitation letter Evidence demonstrates that GP endorsement has a positive effect on cervical screening uptake. The cervical screening programme sends a standard invitation letter and a reminder letter 18 weeks later to women who

2020 Public Health England

96. Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europ

Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europ Position Statement Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Societyof Gastrointestinal Endoscopy (ESGE) Position Statement Authors AdrianSaftoiu 1,2 ,CesareHassan 3 ,MiguelAreia 4,5 ,ManoopS. Bhutani 6 ,RafBisschops 7 ,ErwanBories 8 ,IrinaM. Cazacu 1,6 ,EvelienDekker 9 , PierreH.Deprez 10 ,StephenP.Pereira 11 ,CarloSenore 12 ,RiccardoCapocaccia 13 (...) 10 Departmentof Hepato-Gastroenterology,Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium 11 Institutefor Liver and Digestive Health, Royal Free Hospital Campus, University College London, UK 12 Epidemiology and Screening Unit-CPO, University Hospital Città della Salute e della Scienza, Turin, Italy 13 Editorial Board, Epidemiologia e Prevenzione 14 III Med Klinik, Klinikum Augsburg, Augsburg, Germany 15 Departmentof Gastroenterology and Hepatology, Radboud

2020 European Society of Gastrointestinal Endoscopy

97. Evidence-based Canadian guidelines for tele-retina screening for diabetic retinopathy: recommendations from the Canadian Retina Research Network (CR2N) Tele-Retina Steering Committee

Evidence-based Canadian guidelines for tele-retina screening for diabetic retinopathy: recommendations from the Canadian Retina Research Network (CR2N) Tele-Retina Steering Committee ClinicalKey

2020 CPG Infobase

98. Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening. Full Text available with Trip Pro

Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening. Improved screening methods for women with dense breasts are needed because of their increased risk of breast cancer and of failed early diagnosis by screening mammography.To compare the screening performance of abbreviated breast magnetic resonance imaging (MRI) and digital breast tomosynthesis (DBT) in women with dense breasts.Cross-sectional (...) study with longitudinal follow-up at 48 academic, community hospital, and private practice sites in the United States and Germany, conducted between December 2016 and November 2017 among average-risk women aged 40 to 75 years with heterogeneously dense or extremely dense breasts undergoing routine screening. Follow-up ascertainment of cancer diagnoses was complete through September 12, 2019.All women underwent screening by both DBT and abbreviated breast MRI, performed in randomized order and read

2020 JAMA

99. Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement. Full Text available with Trip Pro

Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement. Dementia (also known as major neurocognitive disorder) is defined by a significant decline in 1 or more cognitive domains that interferes with a person's independence in daily activities. Dementia affects an estimated 2.4 to 5.5 million individuals in the United States, and its prevalence increases with age.To update its 2014 recommendation, the US Preventive Services Task Force (...) (USPSTF) commissioned a review of the evidence on screening for cognitive impairment, including mild cognitive impairment and mild to moderate dementia, in community-dwelling adults, including those 65 years or older residing in independent living facilities.This recommendation applies to community-dwelling older adults 65 years or older, without recognized signs or symptoms of cognitive impairment.The USPSTF concludes that the evidence is lacking, and the balance of benefits and harms of screening

2020 JAMA

100. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Full Text available with Trip Pro

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The WHO Director-General has issued a call for action to eliminate cervical cancer as a public health problem. To help inform global efforts, we modelled potential human papillomavirus (HPV) vaccination and cervical screening scenarios in low-income and lower-middle-income countries (LMICs) to examine the feasibility and timing (...) of elimination at different thresholds, and to estimate the number of cervical cancer cases averted on the path to elimination.The WHO Cervical Cancer Elimination Modelling Consortium (CCEMC), which consists of three independent transmission-dynamic models identified by WHO according to predefined criteria, projected reductions in cervical cancer incidence over time in 78 LMICs for three standardised base-case scenarios: girls-only vaccination; girls-only vaccination and once-lifetime screening; and girls

2020 Lancet